Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced-Doses of Post-Transplant Cyclophosphamide: challenges and review of the literature.

Irene García-Cadenas,Sara Redondo,Albert Esquirol, J M Portos,Silvana Novelli,Silvana Saavedra,Carol Moreno,Ana Garrido,Guadalupe Oñate,Jordi López,Caballero Ana-Carolina,Sara Miqueleiz,Miguel Arguello-Tomas,Javier Briones,Jorge Sierra,Rodrigo Martino

Transplantation and cellular therapy（2023）

引用 0|浏览15

暂无评分

摘要

Reduced doses of PTCy as GVHD prophylaxis for high risk MF patients shows promising results by reducing GVHD incidence without cases of graft failure.

查看译文

关键词

Allogeneic hematopoietic cell transplant,GVHD,Myelofibrosis,Post-transplant Cyclophosphamide,Toxicity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要